Objective:

To inform about the unavailability of various infectious disease laboratory tests as per CDC updates, including the implications for public health.

Key Findings:

• More than two dozen infectious disease tests are currently unavailable, including those for rabies, poxvirus, Epstein-Barr virus, and varicella zoster virus.
• CDC staffing has decreased by 20% to 25%, impacting laboratory operations and test availability.

Interpretation:

The unavailability of these tests may hinder public health responses, particularly for less common pathogens, potentially leading to increased transmission rates.

Limitations:

• The situation may lead to testing gaps, especially for less common infections, which could delay diagnosis and treatment.
• The reliance on state public health laboratories may not fully compensate for the unavailable tests, particularly for rare diseases.

Conclusion:

The CDC is working to restore some tests while supporting state and local partners in accessing necessary public health testing, with expectations of some tests becoming available again in the coming weeks.